Press Archive - Stand Up To Cancer

Press

Read the latest Stand Up To Cancer press releases and announcements to see how we are making an impact.

PRESS RELEASES

June 1, 2020

Convenient Spit Test Helps Women Assess Cancer Risk From the Comfort of Their Own Homes

Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who might have a genetic risk often don’t get tested.
Read More
May 26, 2020

Stand Up To Cancer Hails FDA Approval of Olaparib for Advanced Prostate Cancer

A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.
Read More
May 20, 2020

Jaime Camil Joins Cancer Survivors in New PSA for Stand Up To Cancer® to Encourage Hispanic Participation in Cancer Clinical Trials

Actor and Stand Up To Cancer (SU2C) Ambassador Jaime Camil has joined forces with cancer survivors in a new public service announcement (PSA) campaign to raise awareness with the Hispanic community about cancer clinical trials.
Read More
April 29, 2020

Stand Up To Cancer Hails FDA Approval of Encorafenib + Cetuximab Combination for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Stand Up To Cancer (SU2C) welcomed the recent Food and Drug Administration (FDA) approval this month of encorafenib in combination with cetuximab for patients with advanced BRAF-mutated colorectal cancer.
Read More
April 27, 2020

Stand Up To Cancer Funded Research To Be Presented During The AACR Virtual Meeting 1 – April 27-28, 2020

Stand Up To Cancer® (SU2C)-supported research will be presented during the American Association for Cancer Research Annual (AACR) Virtual Meeting 10 from April 27th to 28th.
Read More
March 30, 2020

New COVID-19 symptom reasearch app recruiting millions of Americans, including healthcare professionals, cancer patients and survivors, to beat the disease

As the COVID-19 coronavirus pandemic grips the US, a new free app is helping to track the onset and progression of symptoms of millions across the nation. The app will help identify those at risk sooner, and help slow the outbreak of the disease. Information about those who remain symptom-free will also support better understanding of COVID-19.
Read More
March 5, 2020

The Pancreatic Cancer Collective Extends Four Research Teams in $16 Million Push for New Therapies

The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded additional funding of up to $16 million to four teams of top researchers as part of its “New Therapies Challenge Grants,” the American Association for Cancer Research (AACR), Scientific Partner of SU2C, announced today.
Read More
January 28, 2020

Stand Up To Cancer Awards 2020 Laura Ziskin Prize in Translational Research To Drs. Leisha A. Emens and Xiang Zhang

Stand Up To Cancer (SU2C) has awarded the 2020 Laura Ziskin Prize in Translational Research to two highly respected clinical investigators who will come together in a novel collaboration between leaders in breast cancer immuno-oncology and tumor immunology for research to further the availability of immune checkpoint inhibitors for breast cancer patients. Dr. Leisha A. Emens, MD, PhD of UPMC Hillman Cancer Center, and Dr. Xiang Zhang, PhD of Baylor College of Medicine will share a $250,000 grant for their year-long research project which was awarded today at the 2020 SU2C Scientific Summit in Santa Monica.
Read More
January 27, 2020

Stand Up To Cancer Announces International Team on Early Detection of Gastric Cancer, World’s 3rd Leading Cause of Cancer Death

Stand Up To Cancer (SU2C) announced today that an international team of experts will take a new approach to fighting the world’s third-leading cause of cancer death -- stomach (or gastric) cancer.
Read More
January 27, 2020

Stand Up To Cancer Announces First-of-Its-Kind Initiative to Increase Diversity in Cancer Clinical Trials

Stand Up To Cancer (SU2C) announced today a groundbreaking initiative to increase minority representation in cancer clinical trials. All future SU2C-supported research grant proposals will now be required to include and address crucial issues related to recruitment and retention of patients from ethnic groups to improve diverse participation in cancer clinical trials. The announcement was made at Stand Up To Cancer’s annual Scientific Summit, which is attended by SU2C’s leadership and 300+ prominent cancer researchers representing each of SU2C’s Dream Teams, Research Teams and individual grants.
Read More

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.